source
- China rises on biotech risk list as US draft rules threaten Chinese biopharma investmentsA recent Signal Survey shows China moving up the biotech industry’s concern list even before the Treasury Department issued draft rules that could curb U.S. investment in Chinese biopharma. The pr…
- First wave of ASH 2026 abstracts released, featuring data from J&J, Servier and AstraZenecaThe American Society of Hematology’s annual meeting is set for New Orleans, Louisiana, a little over a month away. The first batch of abstracts for the conference has been posted, showcasing early…